FR2199995B1 - - Google Patents

Info

Publication number
FR2199995B1
FR2199995B1 FR7333762A FR7333762A FR2199995B1 FR 2199995 B1 FR2199995 B1 FR 2199995B1 FR 7333762 A FR7333762 A FR 7333762A FR 7333762 A FR7333762 A FR 7333762A FR 2199995 B1 FR2199995 B1 FR 2199995B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7333762A
Other versions
FR2199995A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47094972A external-priority patent/JPS5130061B2/ja
Priority claimed from JP3323473A external-priority patent/JPS49117451A/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2199995A1 publication Critical patent/FR2199995A1/fr
Application granted granted Critical
Publication of FR2199995B1 publication Critical patent/FR2199995B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7333762A 1972-09-21 1973-09-20 Expired FR2199995B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP47094972A JPS5130061B2 (fr) 1972-09-21 1972-09-21
JP3323473A JPS49117451A (fr) 1973-03-23 1973-03-23

Publications (2)

Publication Number Publication Date
FR2199995A1 FR2199995A1 (fr) 1974-04-19
FR2199995B1 true FR2199995B1 (fr) 1977-11-10

Family

ID=26371909

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7333762A Expired FR2199995B1 (fr) 1972-09-21 1973-09-20

Country Status (9)

Country Link
US (2) US3962312A (fr)
AR (1) AR209263A1 (fr)
DD (1) DD106358A5 (fr)
DE (1) DE2347630A1 (fr)
ES (1) ES418924A1 (fr)
FR (1) FR2199995B1 (fr)
GB (1) GB1450691A (fr)
LU (1) LU68461A1 (fr)
NL (1) NL7313003A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243595A (en) * 1972-07-13 1981-01-06 Pfizer Inc. 15-Substituted-omega-pentanorprostaglandins
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US4638100A (en) * 1976-01-08 1987-01-20 The Upjohn Company Aromatic or inter-oxa 2-decarboxy-2-hydroxymethyl-PGFα compounds
US4028419A (en) * 1976-01-08 1977-06-07 The Upjoin Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds
US4204079A (en) * 1977-03-17 1980-05-20 The Upjohn Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro PGF1 compounds
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
SE9002596D0 (sv) * 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
US5359095A (en) * 1990-08-08 1994-10-25 Pharmacia Ab Method for synthesis of prostaglandin derivatives
US5223537A (en) * 1991-07-23 1993-06-29 Kabi Pharmacia Ab Method and composition for treatment of gastric and duodenal disorders
WO2011095990A2 (fr) 2010-02-03 2011-08-11 Fdc Limited Procédé pour la purification de prostaglandines et analogues de celles-ci
ES2439619R1 (es) * 2012-07-16 2014-02-27 Universidad Nacional De Educación A Distancia Dispositivo para generación de energía mecánica según un ciclo híbrido Brayton-Rankine regenerativo y equilibrado y procedimiento de uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (fr) * 1970-06-10 1975-02-04
ZA72713B (en) * 1971-02-26 1972-10-25 Ici Ltd Cyclopentane derivatives
JPS4864073A (fr) * 1971-04-30 1973-09-05
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
US3843713A (en) * 1972-04-05 1974-10-22 Ciba Geigy Corp 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge

Also Published As

Publication number Publication date
ES418924A1 (es) 1976-08-01
GB1450691A (en) 1976-09-22
US3962312A (en) 1976-06-08
NL7313003A (fr) 1974-03-25
AR209263A1 (es) 1977-04-15
AU6055473A (en) 1975-03-20
DD106358A5 (fr) 1974-06-12
FR2199995A1 (fr) 1974-04-19
DE2347630A1 (de) 1974-04-11
LU68461A1 (fr) 1974-03-25
US4061865A (en) 1977-12-06

Similar Documents

Publication Publication Date Title
FR2270234B1 (fr)
FR2183929B1 (fr)
FR2199995B1 (fr)
FR2183711B1 (fr)
FR2209569B1 (fr)
FR2183041A1 (fr)
JPS5242432Y2 (fr)
JPS543158Y2 (fr)
JPS5418249B2 (fr)
JPS5444700B2 (fr)
JPS4987248U (fr)
CS149970B1 (fr)
CS168845B1 (fr)
CH576043A5 (fr)
CH564034A5 (fr)
CH562595A5 (fr)
CH562588A5 (fr)
CH559536A5 (fr)
BG22808A3 (fr)
BG21861A3 (fr)
CH563081A5 (fr)
CH576325A5 (fr)
CH576942A5 (fr)
CH579259A5 (fr)
CH563099A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse